# Efficacy of Low Dose Sugammadex in Reversal of NMB in Laparoscopic Barbaric Surgery

> **NCT02713113** · PHASE3 · COMPLETED · sponsor: **Assiut University** · enrollment: 180 (actual)

## Conditions studied

- Bariatric Patients

## Interventions

- **DRUG:** sugammadex reversal of neuromuscular blockade

## Key facts

- **NCT ID:** NCT02713113
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-02
- **Final completion:** 2016-03
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2016-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02713113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02713113, "Efficacy of Low Dose Sugammadex in Reversal of NMB in Laparoscopic Barbaric Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02713113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*